Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Depreciation and Depletion (2016 - 2026)

Myriad Genetics has reported Depreciation and Depletion over the past 12 years, most recently at $4.7 million for Q4 2025.

  • Quarterly Depreciation and Depletion fell 6.0% to $4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.5 million through Dec 2025, up 1.04% year-over-year, with the annual reading at $19.5 million for FY2025, 0.0% changed from the prior year.
  • Depreciation and Depletion was $4.7 million for Q4 2025 at Myriad Genetics, down from $4.8 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $8.7 million in Q1 2023 and troughed at $2.6 million in Q3 2021.
  • The 5-year median for Depreciation and Depletion is $3.8 million (2021), against an average of $4.1 million.
  • Year-over-year, Depreciation and Depletion skyrocketed 210.71% in 2023 and then tumbled 43.68% in 2024.
  • A 5-year view of Depreciation and Depletion shows it stood at $3.2 million in 2021, then decreased by 3.12% to $3.1 million in 2022, then surged by 38.71% to $4.3 million in 2023, then increased by 16.28% to $5.0 million in 2024, then dropped by 6.0% to $4.7 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Depreciation and Depletion are $4.7 million (Q4 2025), $4.8 million (Q3 2025), and $4.9 million (Q2 2025).